118 related articles for article (PubMed ID: 20397919)
1. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
Farhat FS; Kattan J; Ghosn MG
Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
O'connor T; Rustum Y; Levine E; Creaven P
Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of capecitabine in gastric cancer.
Comella P; Franco L; Casaretti R; de Portu S; Menditto E
Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine in gastric cancer.
Bang YJ
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1791-806. PubMed ID: 22117147
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer].
Min N; He BF; Zhang LS; Liao H; Jia YZ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):599-601. PubMed ID: 20335149
[TBL] [Abstract][Full Text] [Related]
10. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
Pozzo C; Barone C
Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine in the treatment of advanced gastric cancer.
Lee JL; Kang YK
Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732
[TBL] [Abstract][Full Text] [Related]
12. The role of chemotherapy in metastatic gastric cancer.
Pasini F; Fraccon AP; DE Manzoni G
Anticancer Res; 2011 Oct; 31(10):3543-54. PubMed ID: 21965776
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine and irinotecan in advanced gastric cancer.
Sharma SP
Lancet Oncol; 2007 Jul; 8(7):577. PubMed ID: 17668483
[No Abstract] [Full Text] [Related]
14. Capecitabine in advanced gastric cancer.
Okines A; Chau I; Cunningham D
Expert Opin Pharmacother; 2007 Nov; 8(16):2851-61. PubMed ID: 17956204
[TBL] [Abstract][Full Text] [Related]
15. Combinational therapy: new hope for pancreatic cancer?
Shi S; Yao W; Xu J; Long J; Liu C; Yu X
Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
[TBL] [Abstract][Full Text] [Related]
16. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
17. Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.
Kang BW; Kim JG; Kwon OK; Chung HY; Yu W
World J Gastroenterol; 2014 May; 20(18):5396-402. PubMed ID: 24833869
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
Fornaro L; Vasile E; Masi G; Loupakis F; Caponi S; Ginocchi L; Falcone A
Ann Oncol; 2010 Jan; 21(1):181. PubMed ID: 19889616
[No Abstract] [Full Text] [Related]
19. [Capecitabine (Ro09-1978) for therapy of advanced and recurrent gastric cancer].
Koizumi W
Nihon Rinsho; 2001 Apr; 59 Suppl 4():398-403. PubMed ID: 11424414
[No Abstract] [Full Text] [Related]
20. Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis.
Cho YH; Yoon SY; Kim SN
Cancer Res Treat; 2017 Jan; 49(1):255-262. PubMed ID: 27188198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
